Related references
Note: Only part of the references are listed.Invited Commentary: The Prevalent New-User Design in Pharmacoepidemiology-Challenges and Opportunities
Kristian B. Filion et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)
Time-related biases in pharmacoepidemiology
Samy Suissa et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies
Chih-Hung Wang et al.
EXPERT OPINION ON DRUG SAFETY (2019)
Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Min Wei et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Accounting for missing data in statistical analyses: multiple imputation is not always the answer
Rachael A. Hughes et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Evaluation of Healthy User Effects With Metformin and Other Oral Antihyperglycemia Medication Users in Adult Patients With Type 2 Diabetes
Maxim Eskin et al.
CANADIAN JOURNAL OF DIABETES (2019)
Principled Approaches to Missing Data in Epidemiologic Studies
Neil J. Perkins et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Multiple Imputation for Incomplete Data in Epidemiologic Studies
Ofer Harel et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism
Christel Renoux et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Missing data and multiple imputation in clinical epidemiological research
Alma B. Pedersen et al.
CLINICAL EPIDEMIOLOGY (2017)
Guidelines for good pharmacoepidemiology practice (GPP)
Elizabeth B. Andrews et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available
Miguel A. Hernan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Confounding by Indication in Clinical Research
Demetrios N. Kyriacou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The lag-time approach improved drug-outcome association estimates in presence of protopathic bias
Andrea Arfe et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
Miguel A. Hernan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
Xiaojuan Mi et al.
STATISTICS IN MEDICINE (2016)
Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations
Dae Hyun Kim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Guidelines for Good Database Selection and use in Pharmacoepidemiology Research
Gillian C. Hall et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension
Joanne LaFleur et al.
HEART (2011)
Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution-A Simulation Study
Til Stuermer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies
Jaclyn L. F. Bosco et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Confounding Control in Healthcare Database Research Challenges and Potential Approaches
M. Alan Brookhart et al.
MEDICAL CARE (2010)
Avoiding Common Pitfalls in the Analysis of Observational Studies of New Treatments for Rheumatoid Arthritis
Marie Hudson et al.
ARTHRITIS CARE & RESEARCH (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Immortal time bias in observational studies of drug effects
Samy Suissa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Application of lag-time into exposure definitions to control for protopathic bias
H. Tamim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
A review of uses of health care utilization databases for epidemiologic research on therapeutics
S Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Channelling of patients taking NSAIDs or cyclooxygenase-2-specific inhibitors and its effect on interpretation of outcomes
TM MacDonald et al.
RHEUMATOLOGY (2003)
Share Paper
